ProMIS Neurosciences Inc PMN

PMN-267

[G1945V]

ProMIS Neurosciences Reports New Milestones in Potential Therapeutic Approaches for Amyotrophic Lateral Sclerosis (ALS)

G1945V

[M101]

Any PMN267 milestone reached is good news, but the statements from Cashman and Altsteil could hardly be more bland. If you're going to make a news release out of it how about quantifying "moved forward as rapidly as possible"?  You call it a milestone reached, well then what's the next one? As is it looks as much contrived to let Larry issue his first official words, whoopee

[azzymaa]

Same old PR's we have seen time and time again. SP is still the lowest it has been in 1 year.  M101 changing the CEO won't accomplish anything. Stage 1,2,3 is tricks to keep the Company going as far as possible for a total Buyout. I don't see anything of value here when Biogen as already halted their programs until further notice. 

[bball67]

AZ, disagree with you. Not the same old PR's. I assume you read the press release and understand it. I don't recall Promis devoting a PR solely to ALS. You diminish and minimize the press release with a large amount of significant content and considerable "milestones". I hope Promis has the answer to this horrible disabling desease. A good friend of mine, a Psychiatrist, came to

[azzymaa]

Bball, just upset that the SP does not change but only dips. Feel sorry for your friend, let's hope Promis speeds things up and comes out with a cure! 

[M101]

I don't recall one either, which is why I think they could do a better job promoting this progress. I don't care which CNS disease is used to validate the platform and central hypothesis, but I would have chosen the quickest path before the biggest market and ALS could still end up providing that path.